Convertible Notes vs. SAFEs: Key Differences, Risks, and Which Is Better for Startups

Abstract hero: note pillar with cyan timer vs SAFE pill, rail to cap table, dilution wedges.
Loading the Elevenlabs Text to Speech AudioNative Player...

Convertible Notes vs. SAFEs: Overview & TL;DR

Both instruments are used to raise money quickly without setting a priced valuation. The tradeoff is that the conversion math can hide real dilution, and treating these as “simple paperwork” can create avoidable securities-compliance and disclosure risk.

  • SAFE (Simple Agreement for Future Equity): a future-equity contract (not debt). YC notes that a SAFE has no expiration/maturity date, reducing pressure to renegotiate extensions and interest terms. (YC SAFE documents)
  • Convertible note: a debt instrument that may convert to equity later, typically with interest and a maturity date (and potential repayment/default leverage if it doesn’t convert).

TL;DR for founders

  • SAFE is usually preferred when you want speed, fewer negotiated terms, and no maturity “cliff.”
  • A note can be better when investors insist on debt protections (maturity, interest, default remedies) or you need a clearer timeline to a priced round.
  • Core risks: hidden dilution from stacked caps/discounts, ambiguous conversion definitions, and “side letter creep” (e.g., MFN/pro rata) that is not tracked. Use a single source of truth for ownership impact (see cap table guidance).

TL;DR for counsel

  • Review hotspots: definition of “Equity Financing,” cap/discount interaction, MFN, pro rata, change-of-control mechanics, and amendment/waiver thresholds across multiple holders.
  • Model for a clean cap table: fully diluted conversion across all SAFEs/notes (including interest on notes), option pool assumptions, and rounding/aggregation so the priced round closes without surprises.

The biggest legal difference is what you are buying: a convertible note is a loan that may later convert; a SAFE is a contract right to receive equity later (no debt). That structural choice drives leverage, enforcement, and how “hard” the investor’s rights feel when timelines slip.

  • Convertible notes = debt. The company owes principal (plus accrued interest) and typically has a maturity date. If the note hasn’t converted by maturity, investors may have default remedies (and negotiation leverage to demand conversion, repayment, or an extension). See our comparison for practical implications: SAFE vs Convertible Note.
  • SAFEs = future equity contracts. YC’s SAFE materials emphasize that a SAFE has no expiration/maturity date, so there’s no maturity-driven default or interest renegotiation cycle. (YC SAFE documents)

Default, acceleration on sale, and remedies

  • Notes: may permit acceleration (due and payable) or conversion on a change of control; failure to pay can trigger enforcement rights typical of debt.
  • SAFEs: usually provide contractual outcomes on a priced round, liquidity event, or dissolution, but do not create creditor-style collection remedies.

Amendments and waivers (and who approves)

  • Expect amendments when extending a note’s maturity, changing interest, redefining a “qualified financing,” or harmonizing terms across a stacked round.
  • Approval is governed by the instrument: many forms require consent of the affected holder(s) and often a specified majority of holders for across-the-board changes — so track holder thresholds and side letters carefully.

Compare Key Economic Terms and Conversion Mechanics (With Examples)

Valuation cap and discount are the two main “economic levers” in both SAFEs and notes. In most market forms, they operate in the alternative — the investor converts at the more favorable price (cap price vs. discounted priced-round price). Convertible notes add a third lever: interest, which increases the amount that converts.

  • Cap: sets a maximum effective valuation for conversion.
  • Discount: converts at a % discount to the next round price (often 10–25%).
  • Note interest: accrued interest typically converts alongside principal, increasing dilution.

Example 1 (note with cap + interest): $100,000 note, 6% interest, 18 months outstanding → ~$109,000 converts. If the priced round is at $20M pre-money but the note has a $10M cap, the conversion price is based on the cap (not $20M), and the extra ~$9,000 interest buys additional shares.

Example 2 (SAFE with cap + discount): $100,000 SAFE, $10M cap, 20% discount. If the Series A is priced at $2.00/share, the discounted price is $1.60/share; if the cap implies $1.20/share, the SAFE converts at $1.20/share (the better deal for the investor).

Example 3 (stacked SAFEs): If you issue multiple post-money SAFEs, each SAFE’s ownership is calculated after “all the SAFE money is accounted for,” which YC highlights as the key post-money feature. (YC SAFE overview) Practically, stacking caps across multiple closes can compound dilution — model every instrument together before signing (see conversion mechanics and dilution modeling).

MFN + pro rata (practical notes)

  • MFN clauses can silently “upgrade” earlier investors to better later terms — track them centrally so the cap table reflects the best applicable economics.
  • Pro rata rights affect allocation in the priced round and can change the fundraising plan; ensure the company can actually honor them (or define cutbacks) without breaking the round.

Documenting & Process: Term Sheets, Side Letters, and Cap Table Updates

Fast financings break when documentation and cap table administration lag behind the money. A consistent “paper trail” matters because SAFEs/notes are still securities, and because side letters (MFN, pro rata, information rights) can change economics without changing the main form.

What to include in a term sheet (even for “simple” rounds)

  • Instrument + form (e.g., YC post-money SAFE vs. convertible note) and whether you’ll use an optional side letter. YC SAFE documents
  • Economic terms: cap, discount, (notes: interest, maturity), and any conversion-on-sale/dissolution treatment.
  • Closing mechanics: minimum/maximum raise, rolling closes, wiring instructions, and what constitutes “first sale” for compliance timelines.

Investor notices & side letters

  • Send a short closing notice confirming amount, date, and the exact executed version (attach PDFs).
  • Track any MFN, pro rata, information rights, or observer rights in a side letter log (the “hidden” cap table).

Process checklist (close + post-close)

  • Board consent (and stockholder consent if required by your charter/investor rights).
  • Collect signatures, accredited investor reps, and countersignature; confirm funds received.
  • Update the cap table the same day: instrument type, cap/discount, note interest start date, MFN/pro rata flags (see Cap Table Guide for Startups).
  • Calendar compliance filings and deliver promised reports under any information rights (missed covenants create friction in the priced round).

Securities Compliance: Exemptions, Filings, and Disclosures

Whether you use a SAFE or a convertible note, you’re still selling a security. Most startups rely on Regulation D (typically Rule 506(b) or 506(c)) to avoid registration — so process discipline matters as much as the form document.

Accredited investors: who qualifies (common categories)

  • Individuals: generally qualify if they have $1M+ net worth excluding primary residence, or $200k income (or $300k joint) in each of the last two years with an expectation of the same this year (Rule 501). See SEC’s overview: Accredited Investors (SEC).
  • Entities: many qualify based on asset tests or status (e.g., certain institutions; entities with >$5M in assets).

How to document investor status

  • 506(b): collect an investor questionnaire and reps/warranties (generally “reasonable belief” standard).
  • 506(c) (general solicitation permitted): you must take reasonable steps to verify accredited status — box-checking alone is typically not enough.

Form D + Blue Sky timing (don’t miss the clock)

  • Form D: file within 15 days after the first sale in the offering (first time an investor is irrevocably committed). See SEC guidance: Filing and Amending a Form D Notice (SEC).
  • State notice filings: for Rule 506 offerings, most states require notice filings/fees; deadlines often track 15 days after first sale in that state (state rules vary).

Practical checklist to avoid solicitation and disclosure mistakes

  • Decide up front: 506(b) (no general solicitation) vs. 506(c) (verify accredited investors).
  • Use consistent risk disclosures and written investor reps (and keep them organized for diligence).
  • Calendar Form D and Blue Sky filings at the first close, not the last.

Long-Term Impacts, Strategy, and When to Use Each Instrument

The “right” instrument is the one that won’t blow up your next priced round. The long-term risk isn’t just dilution — it’s complexity that forces renegotiation with seed holders when your Series A lead wants a clean capitalization story.

How stacked instruments impact a Series A (and beyond)

  • Conversion overhang: multiple SAFEs/notes with different caps, discounts, MFNs, and pro rata rights can make it hard to forecast founder ownership and can slow diligence unless you have a clear model (see dilution modeling).
  • Post-money SAFE stacking: YC explains that SAFEs convert into shares later and emphasizes founders should understand “how much of the company you’ve sold” before it’s too late. (YC: Understanding SAFEs and priced rounds)
  • Phantom liquidation preference risk: if a low cap converts into the next round’s preferred, the SAFE/note holders may effectively receive more liquidation preference per dollar invested than the new money — something counsel should flag early.

Decision playbook

  • Prefer SAFEs when speed matters and you want to avoid maturity extensions and interest accruals.
  • Prefer notes when investors require debt-style protections or you need a forcing function toward a priced round.

When a “weighted” approach can work (and how to manage it)

  • Mixing instruments may be reasonable across time (e.g., early SAFE, later note) only if you standardize definitions (Equity Financing, Liquidity Event), cap table tracking, and consent thresholds.
  • Operationally: adopt a financing policy (standard form, cap/discount bands, side-letter limits) and keep a single pro forma cap table that includes every SAFE/note and right (see cap table guidance).